Latest News and Press Releases
Want to stay updated on the latest news?
-
Denver, CO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- M&C Communications, an expert in public and media relations, today announced it has been selected as the public relations agency of record for Hope...
-
60 Degrees Pharma unveils “B-FREE” Phase 2 trial for chronic babesiosis, engaging patients in naming and supporting Lyme research groups.
-
NORWALK, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Multiple Myeloma Research Foundation® (MMRF®) today announced that a team of hikers, including multiple myeloma patients and advocates, will...
-
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its...
-
Mississauga, ON, July 22, 2025 (GLOBE NEWSWIRE) -- Celiac Canada is proud to announce a new partnership with Conagra Brands Canada to support the expansion of gluten-free food service in healthcare...
-
The Prevent Cancer Foundation wants all people to know that getting screened for cancer (even when you feel fine!) can lead to better health outcomes.
-
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Digital Payments - Global Strategic Business Report"has been added to ResearchAndMarkets.com's offering.The global market for Healthcare...
-
WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
-
The primary study endpoints were related to safety. No dose-limiting toxicities or significant adverse events related to TVGN 489, including Cytokine Release Syndrome, were observed in any patient at...
-
Washington, DC, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the...